Swedbank AB Purchases 170,000 Shares of The Cooper Companies, Inc. $COO

Swedbank AB increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 18.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,074,029 shares of the medical device company’s stock after purchasing an additional 170,000 shares during the period. Swedbank AB’s holdings in Cooper Companies were worth $88,027,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Coldstream Capital Management Inc. increased its position in shares of Cooper Companies by 53.4% during the fourth quarter. Coldstream Capital Management Inc. now owns 7,385 shares of the medical device company’s stock valued at $605,000 after purchasing an additional 2,570 shares during the period. Jefferies Financial Group Inc. increased its position in shares of Cooper Companies by 177.2% during the fourth quarter. Jefferies Financial Group Inc. now owns 59,877 shares of the medical device company’s stock valued at $4,908,000 after purchasing an additional 38,277 shares during the period. Axxcess Wealth Management LLC increased its position in shares of Cooper Companies by 37.1% during the fourth quarter. Axxcess Wealth Management LLC now owns 9,980 shares of the medical device company’s stock valued at $818,000 after purchasing an additional 2,698 shares during the period. Diamond Hill Capital Management Inc. increased its position in shares of Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after purchasing an additional 2,720,594 shares during the period. Finally, Global Retirement Partners LLC increased its position in shares of Cooper Companies by 53.7% during the fourth quarter. Global Retirement Partners LLC now owns 879 shares of the medical device company’s stock valued at $72,000 after purchasing an additional 307 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $62.55 on Friday. The business’s fifty day moving average price is $66.92 and its two-hundred day moving average price is $75.14. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The stock has a market capitalization of $12.20 billion, a price-to-earnings ratio of 30.97, a price-to-earnings-growth ratio of 1.61 and a beta of 0.89. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the prior year, the business posted $0.92 earnings per share. The business’s revenue was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, analysts predict that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Needham & Company LLC boosted their price objective on Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research report on Friday, March 6th. William Blair upgraded Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Barclays upped their price target on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Finally, Rothschild & Co Redburn cut Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research report on Wednesday, March 4th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.